STUDY QUESTION: Do the mRNA expression levels of zona pellucida (ZP) genes, ZP1, 2, 3 and 4 in oocyte and cumulus cells (CC) reveal relevant information on the oocyte?
Introduction
The mammalian zona pellucida (ZP) is an extracellular matrix surrounding oocytes and embryos up to the time of blastocyst hatching. It plays an important role in species-specific sperm-egg binding, induction of acrosome reaction, prevention of polyspermy and protection of the embryo during its transfer through the Fallopian tube (Wassarman et al., 1999) . A functional and well-structured ZP is critical for fertilization, the early stages of embryo development and hatching of the blastocyst.
The human ZP matrix is composed of four glycoproteins designated as ZP1, ZP2, ZP3 and ZP4 (Lefièvre et al., 2004) . It increases in thickness as the oocyte increases in diameter and nascent ZP glycoproteins are incorporated into the thickening ZP matrix at its inner surface, implying that the ZP thickens from the inside to the outside (Wassarman and Albertini, 1994; Qi et al., 2002) . ZP1, 2 and 3 proteins have been described in both human oocytes and granulosa cells as early as the primordial follicle stage using immunohistochemistry (Gook et al., 2008) . ZP4 mRNA has been detected in pools of human mature (metaphase II: MII) oocytes (Lefièvre et al., 2004) and the protein was found in the zona of mature oocytes (Lefièvre et al., 2004) .
The current model of human ZP structure is thought to be similar to the murine ZP, described by Wassarman (1988) , consisting of long heterodimeric filaments of ZP2 and ZP3 which are cross-linked by homodimers of ZP1 (Greve and Wassarman, 1985; Green, 1997) . Based on studies in knockout mice, all zona proteins seem to have a role in maintaining the structure of the ZP, because deletion of only one of these proteins causes defects in the zona matrix (ZP1 and 2) (Rankin et al., 1999) or even its total loss (ZP3) (Rankin et al., 1996 (Rankin et al., , 2001 .
Scanning electron microscopy indicated that the inner ZP undergoes significant structural changes in the fertilized oocyte, rendering the inner zona more compact and dense than the outer region (Sathananthan et al. 1997 , Familiari et al. 2006 . Other studies claimed that some properties of the zona layers might reflect the history of oocyte cytoplasmic maturation (Qi et al., 2002; Liu and Baker, 2003) , suggesting that its molecular structure could identify the oocytes having the best developmental competence for embryonic growth (Montag et al., 2008) , blastocyst formation (Rama Raju et al., 2007) and pregnancy (Madaschi et al., 2009) . The evaluation of the oocyte and its ZP can also be performed using noninvasive techniques, such as polarized light microscopy (PLM) (Shen et al., 2005; Montag et al., 2008; Ebner et al., 2010) . PLM allows the detection of anisotropic structures of the oocyte (e.g. the microtubules of the meiotic spindle and the glycoproteins of the inner layer [IL] of the zona) after illumination with a circularly polarized ray of light. This beam is differentially slowed down by well-organized, anisotropic cell structures, and the birefringent signals that are generated may be measured as 'retardance' by a specific computerized birefringent imageanalysis system (Keefe et al., 2003) .
Moreover, the genetics behind the zona matrix components could open an interesting new perspective regarding the etiology of infertility in patients with oocyte maturation and/or fertilization problems. Cumulus cell (CC) gene expression has been proposed as a noninvasive oocyte quality assay and has been described as predictive of embryo development and pregnancy (for review see Fragouli et al., 2014) . Ephrin-B2 (EFNB2), of which increased expression in the CC has repeatedly been related to an increased likelihood of clinical pregnancy (Wathlet et al., 2012 (Wathlet et al., , 2013 , was also included in the current study.
The present study analyses the relation between PLM-detectable structures, intrinsic oocyte quality markers (oocyte maturation status and fertilization capacity), and ZP1, 2, 3 and 4 mRNA expression level in individual human oocytes and their corresponding CC. This relation is analysed taking into account possible confounding factors linked to the patient's or stimulation cycle characteristics.
This analysis was performed in several steps. First, oocytes were analysed with PLM and the eventual presence of mRNA coding for ZP1, 2, 3 and 4 was quantified in individual human oocytes and their corresponding CC. Second, to confirm the relevance of the mRNA observations, the presence of ZP3 protein in human cumulus oocyte complexes (COC) was documented. Third, the potential effect of oocyte maturity on changes in PLM parameters and the mRNA expression observed in oocytes and CC was investigated. Fourth, the potential covariates of the PLM and gene expression results of mature oocytes and CC were identified. Finally, PLM and gene expression results were investigated as potential predictors for fertilization capacity.
Materials and Methods

Patient population
The study included 98 COC originating from 39 women with a median age of 33.4 years (range 22-42) randomly chosen among those having supernumerary oocytes at the Physiopathology of Reproduction and IVF Unit of S. Anna University Hospital of Torino (Italy).
Infertility causes were male factor (n = 19), female factor (ovulation disorder (n = 5), endometriosis (n = 1), tubal pathology (n = 10), PCO (n = 3)) and idiopathic (n = 1). Institutional review board approval was obtained from the local ethical committee and all patients gave written informed consent.
In order to exclude any bias from intrinsic differences among patients, the clinical and cycle characteristics were recorded: age, BMI, antral follicle count (AFC), Day 3 FSH and estradiol (E 2 ) levels, days of ovarian stimulation, total dose of exogenous FSH, peak circulating E 2 as measured the day of hCG administration, number of retrieved COC, ovarian response (gonadotrophin dose/retrieved COC × 100) (Biasoni et al., 2011) , oocyte maturity (mature oocytes/retrieved COC), proportion of two pronuclei/ intact oocytes after ICSI. Serum FSH and E 2 were measured using specific electro-chemiluminescence immunoassays (Cobas 6000 analyzer, Roche Diagnostics).
From each patient, 4-23 oocytes were retrieved. From these, 1-4 were used for the current study. The patient and cycle characteristics are enumerated in Table I . In 23 patients, only mature oocytes were studied, in 4 only immature oocytes, and in 12 both mature and immature oocytes. The patient and cycle characteristics in the three subgroups based on oocyte maturity were comparable, with no significant differences (Supplementary Table I ). The fertilization capacity in the patients ranged from 25 to 100% and was on average 80%.
For confirming the presence of the ZP protein, 12 COC, collected from 6 additional patients prior to hCG administration, and donated for research, were used. UZ Brussel ethical committee approval was granted and informed consent was obtained from all patients.
Controlled ovarian stimulation, COC retrieval, oocyte and cumulus collection Controlled ovarian stimulation was carried out using the GnRH-agonist buserelin (900 µg per day intranasally; Suprefact, Hoechst, Germany) according to a standard 'long' protocol plus recombinant FSH (Gonal-F, Merck-Serono, Germany) at individually tailored, subcutaneous daily dose (100-450 IU) according to the woman's age, the AFC and the circulating Day 3 FSH. Follicular growth was monitored by serial measurements of circulating E 2 and by transvaginal ultrasound examination performed every second day from stimulation Day 7. When at least two follicles reached 18 mm mean diameter, with appropriate E 2 levels, 10 000 IU hCG (Gonasi HP, IBSA, Switzerland) were administered s.c. Ultrasound-guided oocyte retrieval (OPU) was performed 35-37 h later under local anaesthesia (paracervical block).
Aspirated follicular fluids were observed under a stereomicroscope and COC were washed in buffered medium (Flushing medium, Cook Ltd., Ireland) . Within 4 h of OPU, oocytes and CC were separated from individual COC by gently pipetting in single drops of 100 μl HEPES-buffered medium containing 80 IU/ml hyaluronidase (Synvitro Hyadase, Origio Medicult, Denmark). CC were directly plunged in liquid nitrogen while mature and immature oocytes were examined using PLM and were then snap-frozen. Both CC and oocytes were frozen in conical 2 ml cryovials (Sarstedt, Belgium) and stored at −80°C. A total number of 98 oocytes (80 MII, 10 metaphase I and 8 germinal vesicle (GV)) and the corresponding CC were collected for gene expression analysis this study.
For ZP protein analysis, COC were collected after mild stimulation and prior to the hCG injection from growing antral follicles (6-10 mm). The detailed stimulation was described previously (Guzman et al., 2013) .
PLM
During PLM examination, oocytes were placed on a glass bottom dish (Willco Wells, the Netherlands) in a 10 μl drop of buffered, pre-warmed HEPES-buffered medium covered by mineral oil (Culture Oil, Cook Ltd., Ireland), and kept on a 37°C stage warmer under the microscope (Oosight, CRI, USA). PLM images of the oocytes were collected at ×400 magnification and recorded. The Oosight Meta™ software (Oosight, CRI, USA) coupled with automatic ZP detector was used to acquire data from oocytes, as previously described (Molinari et al., 2012) . The following parameters were automatically measured: average retardance, area and thickness of the IL of the ZP (IL-ZP). In addition, the thickness of the whole ZP was manually measured, by obtaining a line scan across the zona at four different points and calculating the average value, as previously described (Shen et al., 2005) . After PLM analysis, the oocytes were snap-frozen by plunging in liquid nitrogen and were stored at −80°C until genetic analysis.
Quantitative RT-PCR
Quantitative RT-PCR (qRT-PCR) was performed as follows. The total RNA of 98 oocytes and 98 corresponding CC samples was extracted using the RNeasy Micro kit (Qiagen, Westburg, the Netherlands) and the RNeasy DNase-digestion protocol, in which 15 ng/ml poly(dA) (Roche Applied Science, Belgium) and 10 pg Luciferase (Promega, the Netherlands) were added. A total volume of 12 µl RNA was obtained and frozen at −80°C. Reverse transcription was performed using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Belgium) according to the manufacturer's protocol, with a total reaction volume of 20 µl that was subsequently diluted to 40 µl for oocytes and to 110 µl for CC. Negative control samples were generated by omitting the RNA or the reverse transcription enzyme in the reverse transcription reaction, and shown to be blank. All resulting cDNA was stored at −80°C until PCR analysis.
PCR primer design was performed using the Universal Probe Library software (https://www.roche-applied-science.com/sis/rtpcr/upl/index.jsp). Primers were selected to be complementary to the sequence of the four ZP proteins (Table II) . Primers for EFNB2 were described before (Wathlet et al., 2012) . Luciferase was used as exogenous control for oocytes (Sànchez et al., 2009) , whereas ubiquitin C (UBC) and beta-2-Microglobulin (B2M) were used as endogenous controls for CC (Wathlet et al., 2011) .
qRT-PCR was performed on a LightCycler 480 (Roche Diagnostics, Belgium) with 2 μl of cDNA and 8 μl LC480 SYBR Green I Master (Roche Diagnostics, Belgium) reaction mix. After 10 min activation at 95°C, cycling conditions were 10 s at 95°C and 30 s at 60°C for 50 cycles. A log6 dilution series of a synthetic oligonucleotide, corresponding to the amplicon, and no template controls were simultaneously run. The specificity of the PCR products was confirmed, once by sequencing and later by melting curve analysis performed at the end of the amplification. Each sample was tested in triplicate and the standard curves were used to calculate the Values are mean ± SD. AFC, antral follicle count; Ovarian sensitivity = gonadotrophin dose/cumulus oocyte complex (COC) retrieved × 100; Oocyte maturity = # MII/COC retrieved; 2PN = proportion of 2PN/intact oocytes after fertilization, live birth = # live births/single embryo transfer. E 2 , estradiol.
absolute quantity, taking into account the actual PCR efficiency prior to the normalization. ZP4 mRNA was expressed at a lower level than ZP1-3 in the oocytes and was, based on a pilot experiment with the first sample set, considered to be at risk for technical bias. For this reason, ZP4 was not analysed with qRT-PCR in the second set of samples containing mainly additional mature oocytes from the same patients analysed in sample set 1.
Staining ZP3 protein in human oocytes and CC
The protein staining was based on a method published earlier (Mattson and Albertini, 1990 ) with all steps performed at room temperature and for 15 min unless stated differently below. All products were purchased at Sigma Aldrich Belgium unless stated differently. COC were fixed for 1 h at 37°C in a fixation buffer with a pH of 6.9 containing 0.1 M Pipes, 2.5 mM EGTA and 5 mM MgCl 2 6H 2 O (Fisher Scientific, Belgium) and were then washed 3× for 10 min at 37°C in a washing buffer (WB) with 0.2% milk powder, 2% NGS (Gibco, Thermo Fisher Scientific, Belgium) 1% bovine serum albumin fraction V, 0.1 M Glycine and 0.01% Triton X-100. After a permeabilization step of 20 min in 0.4% Triton X-100, COC were incubated for 1 h with the 1/50 primary ZP3 antibody (ab48895, Abcam, UK) and then overnight at 4°C. The next day COC were washed 3× in WB and incubated with the secondary antibody Goat anti-Rabbit IgG Alexa Fluor ® 568 at 1/100 (A-11036, Invitrogen Molecular probes, Belgium) for 1 h. After 3× washing in WB COC were incubated for 30 min with 1/1000 diluted Actin Green 488 Ready Probes (R37110, Molecular probes, Belgium) and COC were then washed 3× in WB and mounted in SlowFade Antifade on a cover slip. As a negative control, the primary antibody was omitted and specificity of the antibody binding was proven by a preabsorption control, where an overnight preabsorption was performed at 4°C with a 5× overload of full length recombinant human ZP3 protein (ab132531, Abcam, UK). Confocal scanning microscopy with an argon-krypton laser (488/568) (IX70 Fluoview 200; Olympus, Belgium) was performed to record the fluorescent and differential interference contrast images. All images from the samples and controls were collected under identical confocal settings, and staining was performed 3× using oocytes from six patients.
Statistical analysis
PCR results were logarithmically transformed to ascertain Gaussian distribution by the Shapiro-Wilk test, and were then expressed as mean ± SD. Between-group differences (e.g. mature versus immature oocytes) were assessed using the two-tailed (un)paired Student's t-test and statistical significance level set at P < 0.05. The direct relation among the different PLM observations and among the different mRNA expression observations was analysed using linear regression (Spearman correlation) with Bonferroni's correction for multiple comparisons, and the statistical significance level was set at P < 0.005.
To exclude any patient-or stimulation-specific bias when relating PLM observations to the different mRNA levels, a multivariate analysis of variance model (M-ANOVA) was built to identify clinical or stimulationdependent parameters having a relation with ZP characteristics of mature oocytes. These parameters were then used as covariates in the multivariate regression model that was built to assess the relation between gene expression and individual oocyte zona characteristics. Subsequently, a stepwise regression model selection was built to assess the relation between fertilization rate and the PLM and gene expressions observations. Also here, the biological parameters identified by the M-ANOVA were allowed as covariates. Interdependence among data was each time assessed by modeling the patient as a random factor. Type III P-values were calculated for each model separately.
Results
Amount of the four ZP mRNAs in oocytes and CC
Of the 98 samples analyzed with PLM, one oocyte and two CC samples did not contain enough total RNA to allow reliable mRNA analysis. This was confirmed by the inability to amplify highly expressed control genes, and most likely is the result of a bad preservation process. These samples were therefore excluded.
Among the four ZP mRNAs, only ZP3 mRNA was expressed highly enough to allow quantitative detection in the majority of individual CC pools (85 out of 96). The qRT-PCR for the other ZP genes gave only one or no detection in the triplicates when analyzing CC mRNA, and were therefore not further considered. In the individual oocytes, quantification of ZP4 mRNA was possible in all, and for ZP1, 2 and 3, mRNA was quantifiable in 97/98 samples. The number of informative samples after qRT-PCR analysis is summarized in Table III. Using absolute expression levels and ZP1 mRNA as reference, the ratio of ZP1/ZP2/ZP3/ZP4 mRNAs was 1/4/14/2 and 1/3/14/1 in immature and mature oocytes, respectively. In immature oocytes, the oocyte expressed 1.8-fold less ZP3 than the surrounding CC (P = 0.026; Fig. 1A ). ZP3 expression in the mature oocytes was 2. ZP, zona pellucida; EFNB2, Ephrin-B2; UBC, Ubiquitin C; B2M, Beta-2-Microglobulin, EFNB2 primer sequences were used according to Wathlet et al. (2012) and UBC and B2M primer sequences were chosen based on Wathlet et al. (2011) and ordered at Primer Design UK.
lower compared to the expression in the CC that surrounded them (P < 0.001, Fig. 1B ).
Oocyte maturity and changes in PLM parameters and gene expression in oocytes and CC
The PLM analysis of the ZP revealed that both the IL-ZP area and thickness were significantly lower in mature than in immature oocytes (P = 0.016 and P = 0.002 respectively; Table IV ). Also the IL-ZP average retardance decreased between immature and mature oocytes (1.2-fold change), although not significantly (P = 0.057). The contribution of IL-ZP to the total ZP thickness was significantly lower in mature oocytes (P = 0.014, with a 1.2-fold change), whereas the total ZP thickness was similar in the two oocyte groups (P = 0.950).
In the oocytes, all ZP mRNAs were detectable and the expression level in mature versus immature oocytes showed a significant decrease in ZP1, 2 and 4 (P = 0.020; P = 0.008 and P = 0.022, respectively, with a fold change of 2, 2.3 and 2.9, respectively; Fig. 2C , D and F), whereas ZP3 expression showed a non-significant decrease (Fig. 2E) .
In the CC, ZP3 gene expression was significantly lower in the CC surrounding mature oocytes compared to the CC of immature oocytes (P = 0.01 with 1.5-fold change; Fig. 2A ), whereas EFNB2 expression in CC was comparable in the two maturation groups (P = 0.789; Fig. 2B ).
A subgroup of 12 patients having both immature and mature oocytes was analysed using a Student's t-test for paired data in order to confirm the above-mentioned findings without any interindividual variation. Similar observations were made for this subpopulation, but did not always reach significance due to the lower sample number. The IL-ZP area, thickness and average retardance appeared to be lower in mature versus immature oocytes, but these differences were not significant (P = 0.489; P = 0.072 and P = 0.158, respectively; not shown). Gene expression of ZP3 in CC was also lower in mature oocytes compared to immature oocytes (1.4-fold change; P = 0.4); the same was observed for ZP1/2/4 expression, which was significantly lower in mature then immature oocytes (fold change of 2.5, 2.4 and 2.4; P = 0.011; P = 0.022; P = 0.026, respectively; not shown).
The regression analysis on the PLM and expression observations made in mature oocytes (Table V) showed that all IL-ZP-related PLM parameters (retardance, area and thickness) were significantly correlated, and oocyte diameter was related to total oocyte diameter (oocyte + ZP). The four ZP genes expressed in the oocytes also showed a strong correlation with one another, while oocyte ZP3 expression was not related to the CC ZP3 expression. The IL-ZP retardance was also correlated to the expression of ZP1, 2 and 4 in the oocytes (Table V) .
Multivariate analysis for covariates of the PLM and gene expression results
M-ANOVA analysis indicated that 4 out of 12 patient and stimulationspecific characteristics were potentially related to PLM parameters; they were age, BMI, peak E 2 level and ovarian response ( were considered as covariates in the multiparametric analysis aimed at determining potential relations between PLM and gene expression observations. Patient's age was significantly related to IL-ZP retardance and area (Type III P-value 0.024 and 0.004, respectively) and almost reached significance for IL-ZP thickness (P = 0.061). IL-ZP retardance was related to ZP1 expression in oocytes (P = 0.016) whereas for IL-ZP Area, the serum peak E 2 was closest to reaching a significant relation (P = 0.072). In concordance with the observed correlation between mRNA levels of the four ZP genes within the oocyte (Table V) , the expression of ZP1 could be replaced by those of ZP2, 3 and 4 retaining the strength of the IL-ZP retardance model. The expression of all ZP genes in oocytes was thus significantly related to IL-retardance. The significant correlation observed (scatterplots) for IL-ZP retardance and area appear in Fig. 3 .
PLM and gene expression in relation to fertilization capacity
According to the M-ANOVA analysis, the fertilization rate observed in the patients depended on four variables. Scatterplots depicting the relation are in Fig. 4 . The strongest correlation was with the oocyte ZP3 expression (Type III P = 0.008) and IL-thickness (P = 0.022). The fertilization capacity also depended on the ovarian response of the patient and the CC gene expression of EFNB2, but this was less prominent (Type III P is, respectively, 0.053 and 0.120). The P value of the model with these four variables was 0.003. The multivariable analysis will prevent the inclusion of correlated variables. IL-retardance is correlated to IL-thickness (Table IV) and can replace it in the above-mentioned formula. This results in a Type III P value = 0.057 for IL-retardance and an overall P value = 0.007. Table III and significance with a two-tailed Student's t-test was obtained at *P < 0.05; **P < 0.01. PLM observations and ZP gene expression results in human oocytes and cumulus cells were considered for this analysis; n, the number of samples. The analysis was performed using a Spearman correlation with Bonferroni correction for multiple comparisons with significance set at P < 0.005.
Using only noninvasive oocyte quality markers, the best prediction model has a P = 0.024 and contains IL-thickness (Type III P = 0.008), ovarian response (Type III P = 0.056) and CC EFNB2 expression (Type III P = 0.193). The formula obtained was then Fertilization rate = 81.49 -7.28 × IL-thickness -0.067 × Ovarian response + 7.86 × log2 EFNB2 in CC. The prediction of fertilization in this formula depends, based on the index and the average values observed, mainly on the IL-thickness and CC EFNB2 expression (respectively, 7.28 × 6.1 = 44.4 and 7.86 × 6.2 = 48.7) and least on ovarian response (0.067 × 197 = 13.2).
ZP3 protein in human oocytes and CC
To confirm the presence of ZP in the CC, human COC were stained for ZP3 protein, and counter stained for F Actin protein and visualized with immunocytochemistry on a confocal scanning microscope. All samples were GV oocytes. For F Actin, a positive staining, lining the cortex of the oocyte and the cumulus membrane (Fig. 5B , C, D and E) was detected. Also some transzonal projections were observed as filaments going through the ZP (Fig. 5B) . For ZP3, a clear staining of the cytoplasm of both oocytes and CC in the focal plane was detected, and representative images are presented ( Fig. 5B and E) . All COC stained with ZP3 demonstrated positive staining in the CC and while scanning through the COC from top to bottom, positive staining was detected in almost every individual CC. No ZP3 staining was detected in the two negative controls, respectively stained without adding primary antibody or after preincubation of the ZP3 antibody with full length ZP3 protein.
Discussion
Earlier experiments from our laboratory used Affymetrix micro arrays to find genes expressed in human CC in relation to oocyte competence (Wathlet et al., 2013) . Surprisingly, ZP3 mRNA was found to be differentially expressed in CC of oocytes demonstrating a higher developmental competence in these arrays. Therefore, we wanted to further investigate the expression of ZP in human cumulus and oocytes using qRT-PCR. In the current study, the expression of the four known ZP mRNA, ZP1, 2, 3 and 4, is analyzed with qRT-PCR in 98 individual human oocytes that were also analyzed with PLM, and in their individual cumulus. CC contamination by leakage of ZP3 mRNA from damaged oocytes is very unlikely as all oocytes in this experiment were evaluated manually with PLM after denudation. The PLM imaging requires a clean observation of the whole ZP for optimal detection and damaged oocytes would have been excluded. Furthermore, confocal immunocytochemistry could confirm the presence of ZP3 protein in the CC. The dotted staining pattern observed in the human GV oocytes is in line with earlier observations in growing mice GV oocytes (Hoodbhoy et al., 2006; Jimenez-Movilla and Dean, 2011) . It reflects the multivesicular aggregates in post golgi structures that transport ZP3 (and ZP2) to the cell surface where it is released from a transmembrane domain and Figure 3 Scatterplots for the correlations observed for IL-retardance and IL-area. Scatterplots depict the significant correlations observed in the multivariate analysis of variance (M-ANOVA) analysis and allow an appreciation of the positive or negative correlations. Each dot represents one observation but these might overlap. Inner layer zona pellucida (IL-ZP) retardance was significantly correlated with the expression of ZP1 in the oocytes (A) and the patients' age (C), and the IL-ZP area was correlated with the patients' age (B) and the serum estradiol (E 2 ) as measured on the day of hCG administration (peak E 2 ) (D).
assembled into the oocyte ZP matrix (Hoodbhoy et al., 2006) . Staining for ZP1, 2 and 3 abutting the nuclei of corona/CC of secondary and antral human follicles has been observed before using conventional peroxidase-based staining (Gook et al., 2008 ). In the current study, the fluorescence-based staining indicated a dotted pattern comparable to the one of the oocyte for ZP3 in the CC. It is currently unknown whether the ZP3 from the CC is also secreted and contributes to the zona of the oocyte. This would need further investigations.
Relative amount of the four ZP mRNAs in oocytes and CC ZP1, 2, 3 and 4 mRNAs were detectable in each individual intact oocyte obtained after standard pharmacological ovulation induction. The ratios of the four ZP mRNAs (1/4/14/2 and 1/3/14/1 for ZP1/2/3/4, in immature and mature oocytes, respectively) confirm that ZP2 and 3 are the main structural components of the ZP. This was also reported in mouse by Green (1997) (1/4/4 ratio for ZP1, 2 and 3 mRNA). Our observations give for the first time evidence that ZP4 and ZP1 expression levels in oocytes are comparable. This could suggest a putative structural role for ZP4 protein in human oocytes, or a minor role in sperm binding and acrosome reaction induction (Gupta et al., 2012) . Given the complexity of the three-dimensional protein structure of the ZP, a change in copy number of specific ZPs at the protein level would most likely affect the fertilization capacity (Monné and Jovine, 2011 ).
An earlier study suggested the presence of ZP1, 2 and 3 in corona cells of secondary and antral human follicles (Gook et al., 2008) , suggesting that CC could contribute to the growth of the zona. In the present study, a minimal, not measurable, amount of ZP1, 2 and 4 mRNAs were found in the CC of the human periovulatory follicle, and only ZP3 mRNA was expressed and quantifiable in almost 90% (85/ 96) of the CC samples. The very low level of ZP1, 2 and 4 mRNA in CC that we observed could be explained by the down-regulating effect of hCG, administered before COC retrieval, on the expression of these genes by CC. This phenomenon was previously reported in rodent CC (Epifano et al., 1995; Agca et al., 2013) , and mouse oocytes (Oliveri et al., 2007) , and appears also in primate CC (up to 100-fold lower ZP2 and 4 mRNA expression 12 h after hCG administration) but did not reach significance due to the limited number of replicates in the microarray experiment (Xu et al., 2011) .
The influence of oocyte maturity
Comparing mature versus immature oocytes, we observed a 1.2-fold decrease in IL-ZP retardance, in line with the observation of Braga, who reported that the percentage of highly birefringent oocytes is higher among immature oocytes (De Almeida Ferreira Braga et al., 2010) . Our study reveals for the first time that a significant thinning of the IL-ZP also occurs during oocyte maturation, witnessed by a significant decrease in the IL-ZP thickness and area, whereas the total ZP thickness did not show any relevant change. This suggests that in mature oocytes ILthinning coincides with the thickening of the middle and/or outer layers of the zona.
In the current study, ZP1, 2 and 4 mRNA expression was significantly decreased in mature versus immature oocytes; whereas ZP3 expression, that was 3-14 times more abundant than the other three ZP genes, showed only a minor and non-significant decrease. The ZP morphological variations observed by PLM could thus be caused by the decreased synthesis of ZP1/2 and 4 mRNA during oocyte maturation. On the other hand, the constant expression of the ZP3 gene in oocytes throughout follicular growth could be linked to its critical role in binding the capacitated spermatozoa and as an inducer of the acrosome reaction (Gupta et al., 2009) .
The ZP3 mRNA expression was significantly lower in the CC of mature follicles compared to that in CC of immature follicles, remaining, however, more abundant than the expression found in the corresponding oocytes. This observation could suggest that CC are the main production site of ZP3 mRNA during oocyte maturation, but also that ZP3 protein synthesis and deposition has a higher importance in the earlier stages of oocyte maturation. The lower mRNA expression levels in CC coupled to mature oocytes was not a general effect since EFNB2 mRNA was not differentially expressed in the CC of oocytes at a different maturation stages. It should, however, be noted that the immature COC analyzed for mRNA expression, may not all represent the normal immature stage, as they were immature despite the hCG bolus.
The expression of genes encoding ZP proteins in the mature oocyte and in CC was related to PLM parameters: IL-ZP retardance was positively related to all ZP mRNAs, but was weaker for ZP3. Why ZP3 expression in oocytes and their corresponding CC are not related is currently unclear. P.D. mainly contributed to the statistical analysis. All authors contributed to the final interpretation of the data, the drafting of the manuscript and all gave their final approval. 
